These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22646091)
1. Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation. Dhatwalia R; Singh H; Oppenheimer M; Sobrado P; Tanner JJ Biochemistry; 2012 Jun; 51(24):4968-79. PubMed ID: 22646091 [TBL] [Abstract][Full Text] [Related]
2. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics. Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209 [TBL] [Abstract][Full Text] [Related]
3. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design. Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860 [TBL] [Abstract][Full Text] [Related]
4. Crystal structures and small-angle x-ray scattering analysis of UDP-galactopyranose mutase from the pathogenic fungus Aspergillus fumigatus. Dhatwalia R; Singh H; Oppenheimer M; Karr DB; Nix JC; Sobrado P; Tanner JJ J Biol Chem; 2012 Mar; 287(12):9041-51. PubMed ID: 22294687 [TBL] [Abstract][Full Text] [Related]
5. Identification of the NAD(P)H binding site of eukaryotic UDP-galactopyranose mutase. Dhatwalia R; Singh H; Solano LM; Oppenheimer M; Robinson RM; Ellerbrock JF; Sobrado P; Tanner JJ J Am Chem Soc; 2012 Oct; 134(43):18132-8. PubMed ID: 23036087 [TBL] [Abstract][Full Text] [Related]
6. Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus. van Straaten KE; Routier FH; Sanders DA J Biol Chem; 2012 Mar; 287(14):10780-90. PubMed ID: 22334662 [TBL] [Abstract][Full Text] [Related]
7. Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease. Oppenheimer M; Valenciano AL; Kizjakina K; Qi J; Sobrado P PLoS One; 2012; 7(3):e32918. PubMed ID: 22448231 [TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase. Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. Partha SK; van Straaten KE; Sanders DA J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401 [TBL] [Abstract][Full Text] [Related]
11. Targeting UDP-galactopyranose mutases from eukaryotic human pathogens. Kizjakina K; Tanner JJ; Sobrado P Curr Pharm Des; 2013; 19(14):2561-73. PubMed ID: 23116395 [TBL] [Abstract][Full Text] [Related]
12. Structure, mechanism, and dynamics of UDP-galactopyranose mutase. Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172 [TBL] [Abstract][Full Text] [Related]